chartexchange

TPST
Tempest Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:25 PM EST
0.30USD-6.966%(-0.02)196,472
Pre-marketNov 18, 2026 9:03:30 AM EST
0.35USD+6.936%(+0.02)
After-hoursNov 18, 2026 4:00:30 PM EST
0.3093USD+1.576%(+0.0048)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Brisbane, CA, USA
Previous Close
$0.33
Beta
0.99
52-Week High
$9.25 2025-11-19
52-Week Low
$0.30 2026-11-17
SMA 50
$0.65
SMA 200
$1.35
Avg. Vol 10D
318,799
Avg. Vol 30D
201,899
Avg. Vol 90D
1.90M
Relative Vol
0.97
12.07M
13.9400%
2,222
Apr 9, 2025 · 1-for-13 (reverse)
TPST Profile

tempest therapeutics is a development-stage biotechnology company advancing small molecule therapeutics that modulate anti-tumor immunity pathways. tempest has a balanced and deep pipeline consisting of first-in-class and best-in-class small molecule therapeutics, which modulate distinct immune response pathways relevant to mounting an effective anti-tumor response. the molecules were developed by inception sciences, a versant ventures affiliated drug discovery engine. tempest has assembled a highly experienced team of small molecule and immuno-oncology drug developers to advance these programs to the clinic across diverse cancers representing significant unmet medical need. tempest is backed by a syndicate of leading us and china based venture capital firms.

TPST Performance
PeriodPriceDateChangeBeta
1W0.382026-11-12-19.84%4.596
1M0.602026-10-19-48.84%2.606
3M1.072026-08-19-71.31%0.952
6M1.782026-05-19-82.75%0.612
1Y4.752025-11-19-93.54%0.987
2Y11.252024-11-19-97.27%—
5Y137.412021-11-19-99.78%2.518
TPST Stock Summary

Tempest Therapeutics, Inc. Common Stock (NASDAQ:TPST) stock price today is $0.31, and today's volume is 196,472. TPST is down 6.202% today. The 30 day average volume is 201,899. TPST market cap is $6.14M with 20.00M shares outstanding.